These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23512667)
1. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo. Willis MS; Wadosky KM; Rodríguez JE; Schisler JC; Lockyer P; Hilliard EG; Glass DJ; Patterson C Cell Biochem Funct; 2014 Jan; 32(1):39-50. PubMed ID: 23512667 [TBL] [Abstract][Full Text] [Related]
2. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo. Willis MS; Schisler JC; Li L; Rodríguez JE; Hilliard EG; Charles PC; Patterson C Circ Res; 2009 Jul; 105(1):80-8. PubMed ID: 19498199 [TBL] [Abstract][Full Text] [Related]
3. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1. Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147 [TBL] [Abstract][Full Text] [Related]
4. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Willis MS; Ike C; Li L; Wang DZ; Glass DJ; Patterson C Circ Res; 2007 Mar; 100(4):456-9. PubMed ID: 17272810 [TBL] [Abstract][Full Text] [Related]
5. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. Witt CC; Witt SH; Lerche S; Labeit D; Back W; Labeit S EMBO J; 2008 Jan; 27(2):350-60. PubMed ID: 18157088 [TBL] [Abstract][Full Text] [Related]
6. Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy. Su M; Wang J; Kang L; Wang Y; Zou Y; Feng X; Wang D; Ahmad F; Zhou X; Hui R; Song L Int J Mol Sci; 2014 May; 15(6):9302-13. PubMed ID: 24865491 [TBL] [Abstract][Full Text] [Related]
7. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A. Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353 [TBL] [Abstract][Full Text] [Related]
8. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model. Nguyen T; Bowen TS; Augstein A; Schauer A; Gasch A; Linke A; Labeit S; Adams V Skelet Muscle; 2020 Apr; 10(1):12. PubMed ID: 32340625 [TBL] [Abstract][Full Text] [Related]
9. MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance. Moriscot AS; Baptista IL; Bogomolovas J; Witt C; Hirner S; Granzier H; Labeit S J Struct Biol; 2010 May; 170(2):344-53. PubMed ID: 20149877 [TBL] [Abstract][Full Text] [Related]
10. Muscle-specific regulation of right ventricular transcriptional responses to chronic hypoxia-induced hypertrophy by the muscle ring finger-1 (MuRF1) ubiquitin ligase in mice. Oakley RH; Campen MJ; Paffett ML; Chen X; Wang Z; Parry TL; Hillhouse C; Cidlowski JA; Willis MS BMC Med Genet; 2018 Sep; 19(1):175. PubMed ID: 30241514 [TBL] [Abstract][Full Text] [Related]
11. Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes. Banerjee R; He J; Spaniel C; Quintana MT; Wang Z; Bain J; Newgard CB; Muehlbauer MJ; Willis MS Metabolomics; 2015 Apr; 11(2):312-322. PubMed ID: 28325996 [TBL] [Abstract][Full Text] [Related]
12. The Role of Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Bone Microarchitecture In Vivo. Suryadevara V; Krehbial CJ; Halsey D; Willis MS Cell Biochem Biophys; 2022 Jun; 80(2):415-426. PubMed ID: 35191000 [TBL] [Abstract][Full Text] [Related]
13. Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling. Wadosky KM; Rodríguez JE; Hite RL; Min JN; Walton BL; Willis MS Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E723-39. PubMed ID: 24425758 [TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase regulates E3 ligases in rodent heart. Baskin KK; Taegtmeyer H Circ Res; 2011 Oct; 109(10):1153-61. PubMed ID: 21921267 [TBL] [Abstract][Full Text] [Related]
15. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo. Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156 [TBL] [Abstract][Full Text] [Related]
16. Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment. Hwee DT; Gomes AV; Bodine SC Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E967-77. PubMed ID: 21828340 [TBL] [Abstract][Full Text] [Related]
17. Rise above: muscle ring-finger-1 (MURF1) regulation of cardiomyocyte size and energy metabolism. Patterson C; Willis MS; Portbury A Trans Am Clin Climatol Assoc; 2011; 122():70-81. PubMed ID: 21686210 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Glucose Metabolism by MuRF1 and Treatment of Myopathy in Diabetic Mice with Small Molecules Targeting MuRF1. Labeit S; Hirner S; Bogomolovas J; Cruz A; Myrzabekova M; Moriscot A; Bowen TS; Adams V Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672385 [TBL] [Abstract][Full Text] [Related]
19. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. He J; Quintana MT; Sullivan J; L Parry T; J Grevengoed T; Schisler JC; Hill JA; Yates CC; Mapanga RF; Essop MF; Stansfield WE; Bain JR; Newgard CB; Muehlbauer MJ; Han Y; Clarke BA; Willis MS Cardiovasc Diabetol; 2015 Aug; 14():97. PubMed ID: 26242235 [TBL] [Abstract][Full Text] [Related]
20. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Castillero E; Alamdari N; Lecker SH; Hasselgren PO Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]